Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 119 entries
Sorted by: Best Match Show Resources per page
Childhood origins of adult resistance to science

adult

Bloom P, Weisberg DS.
GSID: ID9meQIRx1AJ
P Bloom, DS Weisberg - science, 2007 - science.org

Resistance to certain scientific ideas derives in large part from assumptions and biases that can be demonstrated experimentally in young children and that may persist into adulthood. …

Cite
Bloom, P., & Weisberg, D. S. (2007). Childhood origins of adult resistance to science. science, 316(5827), 996-997.
Bloom, Paul, and Deena Skolnick Weisberg. "Childhood origins of adult resistance to science." science 316.5827 (2007): 996-997.
Copy Download .nbib Format: MLA
Long-term disease-specific and cognitive quality of life after intensity-modulated radiation therapy: a cross-sectional survey of nasopharyngeal carcinoma survivors.

Radiation oncology (London, England)

Kiang A, Weinberg VK, Cheung KH, Shugard E, Chen J, Quivey JM, Yom SS.
PMID: 27671196
Radiat Oncol. 2016 Sep 26;11(1):127. doi: 10.1186/s13014-016-0704-9.

BACKGROUND: There is a lack of data on quality of life in long-term survivors of nasopharyngeal carcinoma (NPC) who have been treated with intensity-modulated radiation therapy (IMRT). We characterized long-term disease-specific and cognitive QoL in NPC survivors after IMRT.METHODS:...

Cite
Kiang A, Weinberg VK, Cheung KH, et al. Long-term disease-specific and cognitive quality of life after intensity-modulated radiation therapy: a cross-sectional survey of nasopharyngeal carcinoma survivors. Radiat Oncol. 2016;11(1):127doi: 10.1186/s13014-016-0704-9.
Kiang, A., Weinberg, V. K., Cheung, K. H., Shugard, E., Chen, J., Quivey, J. M., & Yom, S. S. (2016). Long-term disease-specific and cognitive quality of life after intensity-modulated radiation therapy: a cross-sectional survey of nasopharyngeal carcinoma survivors. Radiation oncology (London, England), 11(1), 127. https://doi.org/10.1186/s13014-016-0704-9
Kiang, Alan, et al. "Long-term disease-specific and cognitive quality of life after intensity-modulated radiation therapy: a cross-sectional survey of nasopharyngeal carcinoma survivors." Radiation oncology (London, England) vol. 11,1 (2016): 127. doi: https://doi.org/10.1186/s13014-016-0704-9
Kiang A, Weinberg VK, Cheung KH, Shugard E, Chen J, Quivey JM, Yom SS. Long-term disease-specific and cognitive quality of life after intensity-modulated radiation therapy: a cross-sectional survey of nasopharyngeal carcinoma survivors. Radiat Oncol. 2016 Sep 26;11(1):127. doi: 10.1186/s13014-016-0704-9. PMID: 27671196; PMCID: PMC5036322.
Copy Download .nbib Format: NLM
Good syndrome and other causes of cytomegalovirus retinitis in HIV-negative patients-case report and comprehensive review of the literature.

Journal of ophthalmic inflammation and infection

Downes KM, Tarasewicz D, Weisberg LJ, Cunningham ET.
PMID: 26809342
J Ophthalmic Inflamm Infect. 2016 Dec;6(1):3. doi: 10.1186/s12348-016-0070-7. Epub 2016 Jan 25.

We describe a 65-year-old Thai woman who developed cytomegalovirus retinitis (CMVR) in the setting of Good syndrome-a rare, acquired partial immune deficiency caused by thymoma. The patient subsequently developed vitritis with cystoid macular edema (CME) similar to immune recovery...

Cite
Downes KM, Tarasewicz D, Weisberg LJ, et al. Good syndrome and other causes of cytomegalovirus retinitis in HIV-negative patients-case report and comprehensive review of the literature. J Ophthalmic Inflamm Infect. 2016;6(1):3doi: 10.1186/s12348-016-0070-7.
Downes, K. M., Tarasewicz, D., Weisberg, L. J., & Cunningham, E. T. (2016). Good syndrome and other causes of cytomegalovirus retinitis in HIV-negative patients-case report and comprehensive review of the literature. Journal of ophthalmic inflammation and infection, 6(1), 3. https://doi.org/10.1186/s12348-016-0070-7
Downes, Kenneth M, et al. "Good syndrome and other causes of cytomegalovirus retinitis in HIV-negative patients-case report and comprehensive review of the literature." Journal of ophthalmic inflammation and infection vol. 6,1 (2016): 3. doi: https://doi.org/10.1186/s12348-016-0070-7
Downes KM, Tarasewicz D, Weisberg LJ, Cunningham ET. Good syndrome and other causes of cytomegalovirus retinitis in HIV-negative patients-case report and comprehensive review of the literature. J Ophthalmic Inflamm Infect. 2016 Dec;6(1):3. doi: 10.1186/s12348-016-0070-7. Epub 2016 Jan 25. PMID: 26809342; PMCID: PMC4726639.
Copy Download .nbib Format: NLM
Simultaneous visualization of chromatolytic neurons and neurons retrogradely labeled with horseradish peroxidase.

Neuroscience letters

Weisberg JA, Metz CB.
PMID: 19604881
Neurosci Lett. 1976 Nov;3(4):167-71. doi: 10.1016/0304-3940(76)90068-9.

A method is described for visualization of neurons retrogradely labeled with horseradish peroxidase (HRP) in celloidin-embedded brain slabs. The preservation of cellular detail obtained with this technique facilitates (1) accurate delimination of nuclei or laminae in which HRP-positive neurons...

Cite
Weisberg JA, Metz CB. Simultaneous visualization of chromatolytic neurons and neurons retrogradely labeled with horseradish peroxidase. Neurosci Lett. 1976;3(4):167-71doi: 10.1016/0304-3940(76)90068-9.
Weisberg, J. A., & Metz, C. B. (1976). Simultaneous visualization of chromatolytic neurons and neurons retrogradely labeled with horseradish peroxidase. Neuroscience letters, 3(4), 167-71. https://doi.org/10.1016/0304-3940(76)90068-9
Weisberg, J A, and Metz, C B. "Simultaneous visualization of chromatolytic neurons and neurons retrogradely labeled with horseradish peroxidase." Neuroscience letters vol. 3,4 (1976): 167-71. doi: https://doi.org/10.1016/0304-3940(76)90068-9
Weisberg JA, Metz CB. Simultaneous visualization of chromatolytic neurons and neurons retrogradely labeled with horseradish peroxidase. Neurosci Lett. 1976 Nov;3(4):167-71. doi: 10.1016/0304-3940(76)90068-9. PMID: 19604881.
Copy Download .nbib Format: NLM
Method for measuring changes in surface tension on agar.

Applied and environmental microbiology

Weisberg DS, Dworkin M.
PMID: 16346273
Appl Environ Microbiol. 1983 Apr;45(4):1338-41. doi: 10.1128/aem.45.4.1338-1341.1983.

The surface tension of agar surfaces was determined by measuring the contact angles formed by drops of various hydrophobic liquids on the surface and then calculating the composite surface free energy function by solving a series of simultaneous equations...

Cite
Weisberg DS, Dworkin M. Method for measuring changes in surface tension on agar. Appl Environ Microbiol. 1983;45(4):1338-41doi: 10.1128/aem.45.4.1338-1341.1983.
Weisberg, D. S., & Dworkin, M. (1983). Method for measuring changes in surface tension on agar. Applied and environmental microbiology, 45(4), 1338-41. https://doi.org/10.1128/aem.45.4.1338-1341.1983
Weisberg, D S, and Dworkin, M. "Method for measuring changes in surface tension on agar." Applied and environmental microbiology vol. 45,4 (1983): 1338-41. doi: https://doi.org/10.1128/aem.45.4.1338-1341.1983
Weisberg DS, Dworkin M. Method for measuring changes in surface tension on agar. Appl Environ Microbiol. 1983 Apr;45(4):1338-41. doi: 10.1128/aem.45.4.1338-1341.1983. PMID: 16346273; PMCID: PMC242460.
Copy Download .nbib Format: NLM
Comet 81P/Wild 2 under a microscope.

Science (New York, N.Y.)

Brownlee D, Tsou P, Aléon J, Alexander CM, Araki T, Bajt S, Baratta GA, Bastien R, Bland P, Bleuet P, Borg J, Bradley JP, Brearley A, Brenker F, Brennan S, Bridges JC, Browning ND, Brucato JR, Bullock E, Burchell MJ, Busemann H, Butterworth A, Chaussidon M, Cheuvront A, Chi M, Cintala MJ, Clark BC, Clemett SJ, Cody G, Colangeli L, Cooper G, Cordier P, Daghlian C, Dai Z, D'Hendecourt L, Djouadi Z, Dominguez G, Duxbury T, Dworkin JP, Ebel DS, Economou TE, Fakra S, Fairey SA, Fallon S, Ferrini G, Ferroir T, Fleckenstein H, Floss C, Flynn G, Franchi IA, Fries M, Gainsforth Z, Gallien JP, Genge M, Gilles MK, Gillet P, Gilmour J, Glavin DP, Gounelle M, Grady MM, Graham GA, Grant PG, Green SF, Grossemy F, Grossman L, Grossman JN, Guan Y, Hagiya K, Harvey R, Heck P, Herzog GF, Hoppe P, Hörz F, Huth J, Hutcheon ID, Ignatyev K, Ishii H, Ito M, Jacob D, Jacobsen C, Jacobsen S, Jones S, Joswiak D, Jurewicz A, Kearsley AT, Keller LP, Khodja H, Kilcoyne AL, Kissel J, Krot A, Langenhorst F, Lanzirotti A, Le L, Leshin LA, Leitner J, Lemelle L, Leroux H, Liu MC, Luening K, Lyon I, Macpherson G, Marcus MA, Marhas K, Marty B, Matrajt G, McKeegan K, Meibom A, Mennella V, Messenger K, Messenger S, Mikouchi T, Mostefaoui S, Nakamura T, Nakano T, Newville M, Nittler LR, Ohnishi I, Ohsumi K, Okudaira K, Papanastassiou DA, Palma R, Palumbo ME, Pepin RO, Perkins D, Perronnet M, Pianetta P, Rao W, Rietmeijer FJ, Robert F, Rost D, Rotundi A, Ryan R, Sandford SA, Schwandt CS, See TH, Schlutter D, Sheffield-Parker J, Simionovici A, Simon S, Sitnitsky I, Snead CJ, Spencer MK, Stadermann FJ, Steele A, Stephan T, Stroud R, Susini J, Sutton SR, Suzuki Y, Taheri M, Taylor S, Teslich N, Tomeoka K, Tomioka N, Toppani A, Trigo-Rodríguez JM, Troadec D, Tsuchiyama A, Tuzzolino AJ, Tyliszczak T, Uesugi K, Velbel M, Vellenga J, Vicenzi E, Vincze L, Warren J, Weber I, Weisberg M, Westphal AJ, Wirick S, Wooden D, Wopenka B, Wozniakiewicz P, Wright I, Yabuta H, Yano H, Young ED, Zare RN, Zega T, Ziegler K, Zimmerman L, Zinner E, Zolensky M.
PMID: 17170289
Science. 2006 Dec 15;314(5806):1711-6. doi: 10.1126/science.1135840.

The Stardust spacecraft collected thousands of particles from comet 81P/Wild 2 and returned them to Earth for laboratory study. The preliminary examination of these samples shows that the nonvolatile portion of the comet is an unequilibrated assortment of materials...

Cite
Brownlee D, Tsou P, Aléon J, et al. Comet 81P/Wild 2 under a microscope. Science. 2006;314(5806):1711-6doi: 10.1126/science.1135840.
Brownlee, D., Tsou, P., Aléon, J., Alexander, C. M., Araki, T., Bajt, S., Baratta, G. A., Bastien, R., Bland, P., Bleuet, P., Borg, J., Bradley, J. P., Brearley, A., Brenker, F., Brennan, S., Bridges, J. C., Browning, N. D., Brucato, J. R., Bullock, E., Burchell, M. J., Busemann, H., Butterworth, A., Chaussidon, M., Cheuvront, A., Chi, M., Cintala, M. J., Clark, B. C., Clemett, S. J., Cody, G., Colangeli, L., Cooper, G., Cordier, P., Daghlian, C., Dai, Z., D'Hendecourt, L., Djouadi, Z., Dominguez, G., Duxbury, T., Dworkin, J. P., Ebel, D. S., Economou, T. E., Fakra, S., Fairey, S. A., Fallon, S., Ferrini, G., Ferroir, T., Fleckenstein, H., Floss, C., Flynn, G., Franchi, I. A., Fries, M., Gainsforth, Z., Gallien, J. P., Genge, M., Gilles, M. K., Gillet, P., Gilmour, J., Glavin, D. P., Gounelle, M., Grady, M. M., Graham, G. A., Grant, P. G., Green, S. F., Grossemy, F., Grossman, L., Grossman, J. N., Guan, Y., Hagiya, K., Harvey, R., Heck, P., Herzog, G. F., Hoppe, P., Hörz, F., Huth, J., Hutcheon, I. D., Ignatyev, K., Ishii, H., Ito, M., Jacob, D., Jacobsen, C., Jacobsen, S., Jones, S., Joswiak, D., Jurewicz, A., Kearsley, A. T., Keller, L. P., Khodja, H., Kilcoyne, A. L., Kissel, J., Krot, A., Langenhorst, F., Lanzirotti, A., Le, L., Leshin, L. A., Leitner, J., Lemelle, L., Leroux, H., Liu, M. C., Luening, K., Lyon, I., Macpherson, G., Marcus, M. A., Marhas, K., Marty, B., Matrajt, G., McKeegan, K., Meibom, A., Mennella, V., Messenger, K., Messenger, S., Mikouchi, T., Mostefaoui, S., Nakamura, T., Nakano, T., Newville, M., Nittler, L. R., Ohnishi, I., Ohsumi, K., Okudaira, K., Papanastassiou, D. A., Palma, R., Palumbo, M. E., Pepin, R. O., Perkins, D., Perronnet, M., Pianetta, P., Rao, W., Rietmeijer, F. J., Robert, F., Rost, D., Rotundi, A., Ryan, R., Sandford, S. A., Schwandt, C. S., See, T. H., Schlutter, D., Sheffield-Parker, J., Simionovici, A., Simon, S., Sitnitsky, I., Snead, C. J., Spencer, M. K., Stadermann, F. J., Steele, A., Stephan, T., Stroud, R., Susini, J., Sutton, S. R., Suzuki, Y., Taheri, M., Taylor, S., Teslich, N., Tomeoka, K., Tomioka, N., Toppani, A., Trigo-Rodríguez, J. M., Troadec, D., Tsuchiyama, A., Tuzzolino, A. J., Tyliszczak, T., Uesugi, K., Velbel, M., Vellenga, J., Vicenzi, E., Vincze, L., Warren, J., Weber, I., Weisberg, M., Westphal, A. J., Wirick, S., Wooden, D., Wopenka, B., Wozniakiewicz, P., Wright, I., Yabuta, H., Yano, H., Young, E. D., Zare, R. N., Zega, T., Ziegler, K., Zimmerman, L., Zinner, E., & Zolensky, M. (2006). Comet 81P/Wild 2 under a microscope. Science (New York, N.Y.), 314(5806), 1711-6. https://doi.org/10.1126/science.1135840
Brownlee, Don, et al. "Comet 81P/Wild 2 under a microscope." Science (New York, N.Y.) vol. 314,5806 (2006): 1711-6. doi: https://doi.org/10.1126/science.1135840
Brownlee D, Tsou P, Aléon J, Alexander CM, Araki T, Bajt S, Baratta GA, Bastien R, Bland P, Bleuet P, Borg J, Bradley JP, Brearley A, Brenker F, Brennan S, Bridges JC, Browning ND, Brucato JR, Bullock E, Burchell MJ, Busemann H, Butterworth A, Chaussidon M, Cheuvront A, Chi M, Cintala MJ, Clark BC, Clemett SJ, Cody G, Colangeli L, Cooper G, Cordier P, Daghlian C, Dai Z, D'Hendecourt L, Djouadi Z, Dominguez G, Duxbury T, Dworkin JP, Ebel DS, Economou TE, Fakra S, Fairey SA, Fallon S, Ferrini G, Ferroir T, Fleckenstein H, Floss C, Flynn G, Franchi IA, Fries M, Gainsforth Z, Gallien JP, Genge M, Gilles MK, Gillet P, Gilmour J, Glavin DP, Gounelle M, Grady MM, Graham GA, Grant PG, Green SF, Grossemy F, Grossman L, Grossman JN, Guan Y, Hagiya K, Harvey R, Heck P, Herzog GF, Hoppe P, Hörz F, Huth J, Hutcheon ID, Ignatyev K, Ishii H, Ito M, Jacob D, Jacobsen C, Jacobsen S, Jones S, Joswiak D, Jurewicz A, Kearsley AT, Keller LP, Khodja H, Kilcoyne AL, Kissel J, Krot A, Langenhorst F, Lanzirotti A, Le L, Leshin LA, Leitner J, Lemelle L, Leroux H, Liu MC, Luening K, Lyon I, Macpherson G, Marcus MA, Marhas K, Marty B, Matrajt G, McKeegan K, Meibom A, Mennella V, Messenger K, Messenger S, Mikouchi T, Mostefaoui S, Nakamura T, Nakano T, Newville M, Nittler LR, Ohnishi I, Ohsumi K, Okudaira K, Papanastassiou DA, Palma R, Palumbo ME, Pepin RO, Perkins D, Perronnet M, Pianetta P, Rao W, Rietmeijer FJ, Robert F, Rost D, Rotundi A, Ryan R, Sandford SA, Schwandt CS, See TH, Schlutter D, Sheffield-Parker J, Simionovici A, Simon S, Sitnitsky I, Snead CJ, Spencer MK, Stadermann FJ, Steele A, Stephan T, Stroud R, Susini J, Sutton SR, Suzuki Y, Taheri M, Taylor S, Teslich N, Tomeoka K, Tomioka N, Toppani A, Trigo-Rodríguez JM, Troadec D, Tsuchiyama A, Tuzzolino AJ, Tyliszczak T, Uesugi K, Velbel M, Vellenga J, Vicenzi E, Vincze L, Warren J, Weber I, Weisberg M, Westphal AJ, Wirick S, Wooden D, Wopenka B, Wozniakiewicz P, Wright I, Yabuta H, Yano H, Young ED, Zare RN, Zega T, Ziegler K, Zimmerman L, Zinner E, Zolensky M. Comet 81P/Wild 2 under a microscope. Science. 2006 Dec 15;314(5806):1711-6. doi: 10.1126/science.1135840. PMID: 17170289.
Copy Download .nbib Format: NLM
Characterization of midostaurin as a dual inhibitor of FLT3 and SYK and potentiation of FLT3 inhibition against FLT3-ITD-driven leukemia harboring activated SYK kinase.

Oncotarget

Weisberg EL, Puissant A, Stone R, Sattler M, Buhrlage SJ, Yang J, Manley PW, Meng C, Buonopane M, Daley JF, Lazo S, Wright R, Weinstock DM, Christie AL, Stegmaier K, Griffin JD.
PMID: 28881711
Oncotarget. 2017 Jul 06;8(32):52026-52044. doi: 10.18632/oncotarget.19036. eCollection 2017 Aug 08.

Oncogenic FLT3 kinase is a clinically validated target in acute myeloid leukemia (AML), and both multi-targeted and selective FLT3 inhibitors have been developed. Spleen tyrosine kinase (SYK) has been shown to be activated and increased in FLT3-ITD-positive AML patients,...

Cite
Weisberg EL, Puissant A, Stone R, et al. Characterization of midostaurin as a dual inhibitor of FLT3 and SYK and potentiation of FLT3 inhibition against FLT3-ITD-driven leukemia harboring activated SYK kinase. Oncotarget. 2017;8(32):52026-52044doi: 10.18632/oncotarget.19036.
Weisberg, E. L., Puissant, A., Stone, R., Sattler, M., Buhrlage, S. J., Yang, J., Manley, P. W., Meng, C., Buonopane, M., Daley, J. F., Lazo, S., Wright, R., Weinstock, D. M., Christie, A. L., Stegmaier, K., & Griffin, J. D. (2017). Characterization of midostaurin as a dual inhibitor of FLT3 and SYK and potentiation of FLT3 inhibition against FLT3-ITD-driven leukemia harboring activated SYK kinase. Oncotarget, 8(32), 52026-52044. https://doi.org/10.18632/oncotarget.19036
Weisberg, Ellen L, et al. "Characterization of midostaurin as a dual inhibitor of FLT3 and SYK and potentiation of FLT3 inhibition against FLT3-ITD-driven leukemia harboring activated SYK kinase." Oncotarget vol. 8,32 (2017): 52026-52044. doi: https://doi.org/10.18632/oncotarget.19036
Weisberg EL, Puissant A, Stone R, Sattler M, Buhrlage SJ, Yang J, Manley PW, Meng C, Buonopane M, Daley JF, Lazo S, Wright R, Weinstock DM, Christie AL, Stegmaier K, Griffin JD. Characterization of midostaurin as a dual inhibitor of FLT3 and SYK and potentiation of FLT3 inhibition against FLT3-ITD-driven leukemia harboring activated SYK kinase. Oncotarget. 2017 Jul 06;8(32):52026-52044. doi: 10.18632/oncotarget.19036. eCollection 2017 Aug 08. PMID: 28881711; PMCID: PMC5581010.
Copy Download .nbib Format: NLM
Changes in Musculoskeletal System and Metabolism in Osteoporotic Rats Treated With Urocortin.

Frontiers in endocrinology

Saul D, Geisberg LK, Gehle T, Hoffmann DB, Tezval M, Sehmisch S, Komrakova M.
PMID: 31293517
Front Endocrinol (Lausanne). 2019 Jun 24;10:400. doi: 10.3389/fendo.2019.00400. eCollection 2019.

No abstract available.

Cite
Saul D, Geisberg LK, Gehle T, et al. Changes in Musculoskeletal System and Metabolism in Osteoporotic Rats Treated With Urocortin. Front Endocrinol (Lausanne). 2019;10:400doi: 10.3389/fendo.2019.00400.
Saul, D., Geisberg, L. K., Gehle, T., Hoffmann, D. B., Tezval, M., Sehmisch, S., & Komrakova, M. (2019). Changes in Musculoskeletal System and Metabolism in Osteoporotic Rats Treated With Urocortin. Frontiers in endocrinology, 10400. https://doi.org/10.3389/fendo.2019.00400
Saul, Dominik, et al. "Changes in Musculoskeletal System and Metabolism in Osteoporotic Rats Treated With Urocortin." Frontiers in endocrinology vol. 10 (2019): 400. doi: https://doi.org/10.3389/fendo.2019.00400
Saul D, Geisberg LK, Gehle T, Hoffmann DB, Tezval M, Sehmisch S, Komrakova M. Changes in Musculoskeletal System and Metabolism in Osteoporotic Rats Treated With Urocortin. Front Endocrinol (Lausanne). 2019 Jun 24;10:400. doi: 10.3389/fendo.2019.00400. eCollection 2019. PMID: 31293517; PMCID: PMC6601316.
Copy Download .nbib Format: NLM
Targeting chaperon protein HSP70 as a novel therapeutic strategy for FLT3-ITD-positive acute myeloid leukemia.

Signal transduction and targeted therapy

Hu C, Zou F, Wang A, Miao W, Liang Q, Weisberg EL, Wang Y, Liu J, Wang W, Liu Q.
PMID: 34521806
Signal Transduct Target Ther. 2021 Sep 15;6(1):334. doi: 10.1038/s41392-021-00672-7.

No abstract available.

Cite
Hu C, Zou F, Wang A, et al. Targeting chaperon protein HSP70 as a novel therapeutic strategy for FLT3-ITD-positive acute myeloid leukemia. Signal Transduct Target Ther. 2021;6(1):334doi: 10.1038/s41392-021-00672-7.
Hu, C., Zou, F., Wang, A., Miao, W., Liang, Q., Weisberg, E. L., Wang, Y., Liu, J., Wang, W., & Liu, Q. (2021). Targeting chaperon protein HSP70 as a novel therapeutic strategy for FLT3-ITD-positive acute myeloid leukemia. Signal transduction and targeted therapy, 6(1), 334. https://doi.org/10.1038/s41392-021-00672-7
Hu, Chen, et al. "Targeting chaperon protein HSP70 as a novel therapeutic strategy for FLT3-ITD-positive acute myeloid leukemia." Signal transduction and targeted therapy vol. 6,1 (2021): 334. doi: https://doi.org/10.1038/s41392-021-00672-7
Hu C, Zou F, Wang A, Miao W, Liang Q, Weisberg EL, Wang Y, Liu J, Wang W, Liu Q. Targeting chaperon protein HSP70 as a novel therapeutic strategy for FLT3-ITD-positive acute myeloid leukemia. Signal Transduct Target Ther. 2021 Sep 15;6(1):334. doi: 10.1038/s41392-021-00672-7. PMID: 34521806; PMCID: PMC8440619.
Copy Download .nbib Format: NLM
Importance of Endotoxin Clearance in Endotoxemic Septic Shock: An Analysis From the Evaluating Use of PolymyxinB Hemoperfusion in a Randomized Controlled Trial of Adults Treated for Endotoxemic Septic Shock (EUPHRATES) Trial.

Critical care explorations

Rachoin JS, Foster D, Giese R, Weisberg LS, Klein DJ.
PMID: 32211615
Crit Care Explor. 2020 Feb 24;2(2):e0083. doi: 10.1097/CCE.0000000000000083. eCollection 2020 Feb.

To investigate the relationship between survival and treatment-related reduction in endotoxin activity for patients in the Evaluating Use of PolymyxinB Hemoperfusion in a Randomized controlled trial of Adults Treated for Endotoxemia and Septic shock trial with baseline endotoxin activity...

Cite
Rachoin JS, Foster D, Giese R, et al. Importance of Endotoxin Clearance in Endotoxemic Septic Shock: An Analysis From the Evaluating Use of PolymyxinB Hemoperfusion in a Randomized Controlled Trial of Adults Treated for Endotoxemic Septic Shock (EUPHRATES) Trial. Crit Care Explor. 2020;2(2):e0083doi: 10.1097/CCE.0000000000000083.
Rachoin, J. S., Foster, D., Giese, R., Weisberg, L. S., & Klein, D. J. (2020). Importance of Endotoxin Clearance in Endotoxemic Septic Shock: An Analysis From the Evaluating Use of PolymyxinB Hemoperfusion in a Randomized Controlled Trial of Adults Treated for Endotoxemic Septic Shock (EUPHRATES) Trial. Critical care explorations, 2(2), e0083. https://doi.org/10.1097/CCE.0000000000000083
Rachoin, Jean-Sebastien, et al. "Importance of Endotoxin Clearance in Endotoxemic Septic Shock: An Analysis From the Evaluating Use of PolymyxinB Hemoperfusion in a Randomized Controlled Trial of Adults Treated for Endotoxemic Septic Shock (EUPHRATES) Trial." Critical care explorations vol. 2,2 (2020): e0083. doi: https://doi.org/10.1097/CCE.0000000000000083
Rachoin JS, Foster D, Giese R, Weisberg LS, Klein DJ. Importance of Endotoxin Clearance in Endotoxemic Septic Shock: An Analysis From the Evaluating Use of PolymyxinB Hemoperfusion in a Randomized Controlled Trial of Adults Treated for Endotoxemic Septic Shock (EUPHRATES) Trial. Crit Care Explor. 2020 Feb 24;2(2):e0083. doi: 10.1097/CCE.0000000000000083. eCollection 2020 Feb. PMID: 32211615; PMCID: PMC7069594.
Copy Download .nbib Format: NLM
Clinical, immunophenotypic and genomic findings of NK lymphoblastic leukemia: a study from the Bone Marrow Pathology Group.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc

Weinberg OK, Chisholm KM, Ok CY, Fedoriw Y, Grzywacz B, Kurzer JH, Mason EF, Moser KA, Bhattacharya S, Xu M, Babu D, Foucar K, Tam W, Bagg A, Orazi A, George TI, Wang W, Wang SA, Arber DA, Hasserjian RP.
PMID: 33526873
Mod Pathol. 2021 Jul;34(7):1358-1366. doi: 10.1038/s41379-021-00739-4. Epub 2021 Feb 01.

Natural killer (NK) cells are lymphocytes of the native immune system that play a pivotal role in host defense and immune surveillance. While the conceptual view of NK-neoplasms is evolving, little is known about the rare NK lymphoblastic leukemia...

Cite
Weinberg OK, Chisholm KM, Ok CY, et al. Clinical, immunophenotypic and genomic findings of NK lymphoblastic leukemia: a study from the Bone Marrow Pathology Group. Mod Pathol. 2021;34(7):1358-1366doi: 10.1038/s41379-021-00739-4.
Weinberg, O. K., Chisholm, K. M., Ok, C. Y., Fedoriw, Y., Grzywacz, B., Kurzer, J. H., Mason, E. F., Moser, K. A., Bhattacharya, S., Xu, M., Babu, D., Foucar, K., Tam, W., Bagg, A., Orazi, A., George, T. I., Wang, W., Wang, S. A., Arber, D. A., & Hasserjian, R. P. (2021). Clinical, immunophenotypic and genomic findings of NK lymphoblastic leukemia: a study from the Bone Marrow Pathology Group. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, 34(7), 1358-1366. https://doi.org/10.1038/s41379-021-00739-4
Weinberg, Olga K, et al. "Clinical, immunophenotypic and genomic findings of NK lymphoblastic leukemia: a study from the Bone Marrow Pathology Group." Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc vol. 34,7 (2021): 1358-1366. doi: https://doi.org/10.1038/s41379-021-00739-4
Weinberg OK, Chisholm KM, Ok CY, Fedoriw Y, Grzywacz B, Kurzer JH, Mason EF, Moser KA, Bhattacharya S, Xu M, Babu D, Foucar K, Tam W, Bagg A, Orazi A, George TI, Wang W, Wang SA, Arber DA, Hasserjian RP. Clinical, immunophenotypic and genomic findings of NK lymphoblastic leukemia: a study from the Bone Marrow Pathology Group. Mod Pathol. 2021 Jul;34(7):1358-1366. doi: 10.1038/s41379-021-00739-4. Epub 2021 Feb 01. PMID: 33526873.
Copy Download .nbib Format: NLM
Not Only for Career Networking: Can LinkedIn Be Used for Radiology Education?.

Current problems in diagnostic radiology

Kauffman L, Weisberg EM, Fishman EK.
PMID: 34210558
Curr Probl Diagn Radiol. 2021 Jun 06; doi: 10.1067/j.cpradiol.2021.05.004. Epub 2021 Jun 06.

LinkedIn was a social media pioneer website initially focused on improving how professionals conduct business on the Internet. Since its acquisition by Microsoft, it has grown into one of the world's most influential social media platforms and become a...

Cite
Kauffman L, Weisberg EM, Fishman EK. Not Only for Career Networking: Can LinkedIn Be Used for Radiology Education?. Curr Probl Diagn Radiol. 2021;doi: 10.1067/j.cpradiol.2021.05.004.
Kauffman, L., Weisberg, E. M., & Fishman, E. K. (2021). Not Only for Career Networking: Can LinkedIn Be Used for Radiology Education?. Current problems in diagnostic radiology, . https://doi.org/10.1067/j.cpradiol.2021.05.004
Kauffman, Lilly, et al. "Not Only for Career Networking: Can LinkedIn Be Used for Radiology Education?." Current problems in diagnostic radiology vol. (2021). doi: https://doi.org/10.1067/j.cpradiol.2021.05.004
Kauffman L, Weisberg EM, Fishman EK. Not Only for Career Networking: Can LinkedIn Be Used for Radiology Education?. Curr Probl Diagn Radiol. 2021 Jun 06; doi: 10.1067/j.cpradiol.2021.05.004. Epub 2021 Jun 06. PMID: 34210558.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 119 entries